首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
A phase I trial of a single high dose of idarubicin combined with high dose cytarabine (ARA-C) as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia (ALL).
被引:0
|
作者
:
Weiss, M
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
Weiss, M
[
1
]
Maslak, P
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
Maslak, P
[
1
]
Megherian, L
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
Megherian, L
[
1
]
Scheinberg, D
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
Scheinberg, D
[
1
]
机构
:
[1]
MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
来源
:
BLOOD
|
1995年
/ 86卷
/ 10期
关键词
:
D O I
:
暂无
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:3131 / 3131
页数:1
相关论文
共 50 条
[1]
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
Weiss, MA
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
Weiss, MA
Drullinsky, P
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
Drullinsky, P
Maslak, P
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
Maslak, P
Scheinberg, D
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
Scheinberg, D
Golde, DW
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
Golde, DW
[J].
LEUKEMIA,
1998,
12
(06)
: 865
-
868
[2]
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
MA Weiss
论文数:
0
引用数:
0
h-index:
0
机构:
Memorial Sloan-Kettering Cancer Center and Cornell University Medical College,Division of Hematologic Oncology, Department of Medicine
MA Weiss
P Drullinsky
论文数:
0
引用数:
0
h-index:
0
机构:
Memorial Sloan-Kettering Cancer Center and Cornell University Medical College,Division of Hematologic Oncology, Department of Medicine
P Drullinsky
P Maslak
论文数:
0
引用数:
0
h-index:
0
机构:
Memorial Sloan-Kettering Cancer Center and Cornell University Medical College,Division of Hematologic Oncology, Department of Medicine
P Maslak
D Scheinberg
论文数:
0
引用数:
0
h-index:
0
机构:
Memorial Sloan-Kettering Cancer Center and Cornell University Medical College,Division of Hematologic Oncology, Department of Medicine
D Scheinberg
DW Golde
论文数:
0
引用数:
0
h-index:
0
机构:
Memorial Sloan-Kettering Cancer Center and Cornell University Medical College,Division of Hematologic Oncology, Department of Medicine
DW Golde
[J].
Leukemia,
1998,
12
: 865
-
868
[3]
Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL).
Weiss, MA
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Weiss, MA
Aliff, TB
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Aliff, TB
Tallman, MS
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Tallman, MS
Frankel, SR
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Frankel, SR
Kalaycio, ME
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Kalaycio, ME
Maslak, PG
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Maslak, PG
Scheinberg, DA
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Scheinberg, DA
Roma, TE
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
Roma, TE
[J].
BLOOD,
2000,
96
(11)
: 719A
-
719A
[4]
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia
Weiss, MA
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Weiss, MA
Aliff, TB
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Aliff, TB
Tallman, MS
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Tallman, MS
Frankel, SR
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Frankel, SR
Kalaycio, ME
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Kalaycio, ME
Maslak, PG
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Maslak, PG
Jurcic, JG
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Jurcic, JG
Scheinberg, DA
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Scheinberg, DA
Roma, TE
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
Roma, TE
[J].
CANCER,
2002,
95
(03)
: 581
-
587
[5]
High dose ara-C as upfront therapy for adult patients with acute lymphoblastic leukemia (ALL).
Hallbook, H
论文数:
0
引用数:
0
h-index:
0
Hallbook, H
Simonsson, B
论文数:
0
引用数:
0
h-index:
0
Simonsson, B
Bjorkholm, M
论文数:
0
引用数:
0
h-index:
0
Bjorkholm, M
Braide, I
论文数:
0
引用数:
0
h-index:
0
Braide, I
Carneskog, J
论文数:
0
引用数:
0
h-index:
0
Carneskog, J
Grimfors, G
论文数:
0
引用数:
0
h-index:
0
Grimfors, G
Hast, R
论文数:
0
引用数:
0
h-index:
0
Hast, R
Karlsson, R
论文数:
0
引用数:
0
h-index:
0
Karlsson, R
Kimby, E
论文数:
0
引用数:
0
h-index:
0
Kimby, E
Lerner, R
论文数:
0
引用数:
0
h-index:
0
Lerner, R
Linder, O
论文数:
0
引用数:
0
h-index:
0
Linder, O
Linderholm, M
论文数:
0
引用数:
0
h-index:
0
Linderholm, M
Lofvenberg, E
论文数:
0
引用数:
0
h-index:
0
Lofvenberg, E
Malm, PG
论文数:
0
引用数:
0
h-index:
0
Malm, PG
Nilsson, PG
论文数:
0
引用数:
0
h-index:
0
Nilsson, PG
Paul, C
论文数:
0
引用数:
0
h-index:
0
Paul, C
Petrescu, A
论文数:
0
引用数:
0
h-index:
0
Petrescu, A
Rodjer, S
论文数:
0
引用数:
0
h-index:
0
Rodjer, S
Tidefelt, U
论文数:
0
引用数:
0
h-index:
0
Tidefelt, U
Turesson, I
论文数:
0
引用数:
0
h-index:
0
Turesson, I
Uden-Blohme, AM
论文数:
0
引用数:
0
h-index:
0
Uden-Blohme, AM
Vilen, L
论文数:
0
引用数:
0
h-index:
0
Vilen, L
Winquist, I
论文数:
0
引用数:
0
h-index:
0
Winquist, I
Zettervall, O
论文数:
0
引用数:
0
h-index:
0
Zettervall, O
Smedmyr, B
论文数:
0
引用数:
0
h-index:
0
Smedmyr, B
[J].
BLOOD,
1999,
94
(10)
: 297A
-
297A
[6]
High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia:: a pharmacokinetic and clinical study
Tedeschi, Alessandra
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Tedeschi, Alessandra
Montillo, Marco
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Montillo, Marco
Strocchi, Elena
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Strocchi, Elena
Cafro, Anna Maria
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Cafro, Anna Maria
Tresoldi, Elisabetta
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Tresoldi, Elisabetta
Intropido, Liliana
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Intropido, Liliana
Nichelatti, Michele
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Nichelatti, Michele
Marbello, Laura
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Marbello, Laura
Barate, Claudia
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Barate, Claudia
Camaggi, Carlo Maurizio
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Camaggi, Carlo Maurizio
Morra, Enrica
论文数:
0
引用数:
0
h-index:
0
机构:
Osped Niguarda Ca Granda, Dept Hematol Oncol, Div Hematol, I-20162 Milan, Italy
Morra, Enrica
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2007,
59
(06)
: 771
-
779
[7]
High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study
Alessandra Tedeschi
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Alessandra Tedeschi
Marco Montillo
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Marco Montillo
Elena Strocchi
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Elena Strocchi
Anna Maria Cafro
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Anna Maria Cafro
Elisabetta Tresoldi
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Elisabetta Tresoldi
Liliana Intropido
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Liliana Intropido
Michele Nichelatti
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Michele Nichelatti
Laura Marbello
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Laura Marbello
Claudia Baratè
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Claudia Baratè
Carlo Maurizio Camaggi
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Carlo Maurizio Camaggi
Enrica Morra
论文数:
0
引用数:
0
h-index:
0
机构:
Niguarda Ca’ Granda Hospital,Department of Oncology/Hematology, Division of Hematology
Enrica Morra
[J].
Cancer Chemotherapy and Pharmacology,
2007,
59
: 771
-
779
[8]
A single high dose of idarubicin combined with high dose ARA-C for the treatment of first recurrent childhood "high-risk" acute lymphoblastic leukemia (ALL).
Testi, AM
论文数:
0
引用数:
0
h-index:
0
Testi, AM
Del Giudice, I
论文数:
0
引用数:
0
h-index:
0
Del Giudice, I
Arcese, W
论文数:
0
引用数:
0
h-index:
0
Arcese, W
Moleti, ML
论文数:
0
引用数:
0
h-index:
0
Moleti, ML
Giona, F
论文数:
0
引用数:
0
h-index:
0
Giona, F
Arico, M
论文数:
0
引用数:
0
h-index:
0
Arico, M
Basso, G
论文数:
0
引用数:
0
h-index:
0
Basso, G
Conter, V
论文数:
0
引用数:
0
h-index:
0
Conter, V
Messina, C
论文数:
0
引用数:
0
h-index:
0
Messina, C
Rondelli, R
论文数:
0
引用数:
0
h-index:
0
Rondelli, R
Uderzo, C
论文数:
0
引用数:
0
h-index:
0
Uderzo, C
Micalizzi, MC
论文数:
0
引用数:
0
h-index:
0
Micalizzi, MC
Barisone, E
论文数:
0
引用数:
0
h-index:
0
Barisone, E
Locatelli, F
论文数:
0
引用数:
0
h-index:
0
Locatelli, F
Dini, G
论文数:
0
引用数:
0
h-index:
0
Dini, G
Casale, F
论文数:
0
引用数:
0
h-index:
0
Casale, F
Valsecchi, MG
论文数:
0
引用数:
0
h-index:
0
Valsecchi, MG
Masera, G
论文数:
0
引用数:
0
h-index:
0
Masera, G
Mandelli, F
论文数:
0
引用数:
0
h-index:
0
Mandelli, F
[J].
BLOOD,
2000,
96
(11)
: 719A
-
719A
[9]
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
Rosen, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Rosen, PJ
Rankin, C
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Rankin, C
Head, DR
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Head, DR
Boldt, DH
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Boldt, DH
Luthardt, FW
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Luthardt, FW
Norwood, T
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Norwood, T
Pugh, RP
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Pugh, RP
Karanes, C
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Karanes, C
Appelbaum, FR
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
Appelbaum, FR
[J].
LEUKEMIA RESEARCH,
2000,
24
(03)
: 183
-
187
[10]
IDARUBICIN AND HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS
SPIRITI, MAA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
SPIRITI, MAA
TESTI, AM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
TESTI, AM
AMADORI, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
AMADORI, S
DEFABRITIIS, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
DEFABRITIIS, P
GIONA, F
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
GIONA, F
SANDRELLI, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
SANDRELLI, A
MELONI, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
UNIV ROME LA SAPIENZA,INST HAEMATOL,I-00185 ROME,ITALY
MELONI, G
[J].
ACTA HAEMATOLOGICA,
1987,
78
: 213
-
213
←
1
2
3
4
5
→